SWOT Analysis for Bharat Parenterals Ltd. - Opportunity

Add SWOT widget to your site/app

Positive Breakout Second Resistance ( LTP > R2)

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Increasing Revenue every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Stock with Low PE (PE < = 10)

Stocks in uptrend most likely to cross above SMA-200 soon

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Red Flag: High Interest Payments Compared to Earnings

Momentum Trap (DVM)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Risky Value (DVM)

Low durability companies

Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Major fall in TTM Net Profit

Declining profitability: Falling ROCE

Stocks rising sharply on very low month volumes

Bullish or Bearish Candlestick Strength - Indices

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Declining Net Cash Flow and Cash from Operating Activity for last 2 years

Decline in Net Profit with falling Profit Margin (QoQ)